Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants With Mild to Moderate Alzheimer's Disease

NCT05686044 is registered in ClinicalTrials.gov with Annovis Bio Inc. as lead sponsor.

NCT NCT05686044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05686044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants With Mild to Moderate Alzheimer's Disease
Lead sponsor
Annovis Bio Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
April 1, 2023
Completion date
February 13, 2024
Enrollment
351 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease